Unlike today's crop of commercially approved CAR-T therapies that rely on viral vectors, GenomeFrontier is pursuing a ...
As one of the chief players in the automated cell therapy manufacturing space grapples with a recent setback, another is ...
GlobalData on MSN
Cellares and GenomeFrontier to assess automated GF-CART01 production
The partnership aims to assist GenomeFrontier’s clinical activities for GF-CART01 in the US.
For many decades, businesses have focused their manufacturing operations in faraway production locations where labor and shipping costs are traditionally more affordable. However, recent global ...
Manufacturers can gain more value from automation by connecting operational data, employee knowledge and continuous ...
Cellares, the first Integrated Development and Manufacturing Organization (IDMO), and GenomeFrontier Therapeutics, a Taiwanese cell therapy company developing novel virus-free CAR-T therapies, today ...
Adoption of artificial intelligence (AI) has increased more quickly within manufacturing than sectors such as construction or transport, and its use is quickly becoming more mainstream in our industry ...
Expertise from Forbes Councils members, operated under license. Opinions expressed are those of the author. AI is going to make automation more widespread and even more reliable. Based on the ...
Jake Hall, the Manufacturing Millennial, discusses how AI and automation are tools to help workers be more efficient in manufacturing.
How innovative companies are applying AI, computer vision, and 5G to transform their production. T he revival of American industry is underway despite pervasive challenges such as labor and supply ...
In this free webinar, you’ll learn how AI enables automation systems to learn, adapt, and make complex decisions.
Opinions expressed by Entrepreneur contributors are their own. I recently took part in The EMS (Eric Miscoll Show), a biweekly panel discussion exploring all things manufacturing, and perhaps more ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results